Technical Analysis for PETQ - PetIQ, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 16.53 | -0.42% | -0.07 |
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Up 3 Days in a Row | Strength | -0.42% | |
| Up 4 Days in a Row | Strength | -0.42% | |
| Oversold Stochastic | Weakness | -0.42% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.12% | |
| NR7 | Range Contraction | 0.12% | |
| Up 3 Days in a Row | Strength | 0.12% |
| Alert | Time |
|---|---|
| Possible NR7 | about 17 hours ago |
| Possible Inside Day | about 17 hours ago |
| 60 Minute Opening Range Breakdown | about 21 hours ago |
| 60 Minute Opening Range Breakout | 1 day ago |
| Up 1% | 1 day ago |
Get a Trading Assistant
- Earnings date: 05/07/2024
PetIQ, Inc. Description
PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Retail Store Drugs Pain Diabetes Antibiotics Dog Control Products Arthritis Wellness Products Insecticide Rheumatology E Commerce Channels Wellness Rimadyl
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 22.98 |
| 52 Week Low | 11.26 |
| Average Volume | 305,901 |
| 200-Day Moving Average | 18.29 |
| 50-Day Moving Average | 17.33 |
| 20-Day Moving Average | 17.31 |
| 10-Day Moving Average | 16.40 |
| Average True Range | 0.57 |
| RSI (14) | 42.86 |
| ADX | 18.95 |
| +DI | 18.55 |
| -DI | 23.13 |
| Chandelier Exit (Long, 3 ATRs) | 17.44 |
| Chandelier Exit (Short, 3 ATRs) | 17.47 |
| Upper Bollinger Bands | 19.28 |
| Lower Bollinger Band | 15.35 |
| Percent B (%b) | 0.3 |
| BandWidth | 22.67 |
| MACD Line | -0.32 |
| MACD Signal Line | -0.22 |
| MACD Histogram | -0.0963 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.86 | ||||
| Resistance 3 (R3) | 16.87 | 16.77 | 16.81 | ||
| Resistance 2 (R2) | 16.77 | 16.69 | 16.77 | 16.79 | |
| Resistance 1 (R1) | 16.65 | 16.63 | 16.60 | 16.64 | 16.77 |
| Pivot Point | 16.55 | 16.55 | 16.53 | 16.55 | 16.55 |
| Support 1 (S1) | 16.43 | 16.47 | 16.38 | 16.42 | 16.29 |
| Support 2 (S2) | 16.33 | 16.41 | 16.33 | 16.27 | |
| Support 3 (S3) | 16.21 | 16.33 | 16.26 | ||
| Support 4 (S4) | 16.20 |
